Zobrazeno 1 - 3
of 3
pro vyhledávání: '"RM Act, the Act on the Safety of Regenerative Medicine"'
Autor:
Shinya Yamanaka, Kentaro Azuma
Publikováno v:
Regenerative Therapy
In Japan, a research center network consisting of Kyoto University to provide clinical-grade induced Pluripotent Stem Cells (iPSC) and several major research centers to develop iPSC-based regenerative therapies was formed for the clinical application
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1957840a9fc1e64016dea9e17fb6c65
http://hdl.handle.net/2433/242857
http://hdl.handle.net/2433/242857
Autor:
Azuma K; Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan., Yamanaka S; Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.; Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, USA.
Publikováno v:
Regenerative therapy [Regen Ther] 2016 Mar 01; Vol. 4, pp. 36-47. Date of Electronic Publication: 2016 Mar 01 (Print Publication: 2016).
Autor:
Adrian P. Gee
This new edition presents a fully-updated and expanded look at current Good Manufacturing Practice (cGMP) for cell therapy products. It provides a complete discussion of facility design and operation including details specific to cord blood banki
